In-house Products
SK bioscience develops vaccines with its innovative technology and produces them under a strict quality control system.
World´s first developed cell-cultured quadrivalent influenza vaccine (WHO PQ Certification)
SKYCellflu quadrivalent
(Cell-cultured surface antigen influenza vaccine)
Korea´s first domestically developed cell-cultured trivalent influenza vaccine (WHO PQ Certification)
SKYCellflu trivalent
(Cell-cultured surface antigen influenza vaccine)
Korea´s first domestically developed herpes zoster vaccine
SKYZoster
(Live zoster virus vaccine)
Korea´s second domestically developed varicella vaccine (WHO PQ Certification)
SKYVaricella
(Live varicella virus vaccine)
Korea´s first domestically developed typhoid protein conjugate vaccine (WHO PQ Certification)
SKYTyphoid (Export)
(Typhoid Vi Polysaccharide Conjugated to Diphtheria Toxoid vaccine)
Korea´s first domestically developed COVID-19 vaccine
SKYCovion
(SARS-CoV-2 surface antigen vaccine (genetically recombined))
